Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers
Pinkus Tober‐Lau, Tatjana Schwarz, Kanika Vanshylla, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 11, pp. e104-e105
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
Henning Gruell, Kanika Vanshylla, Pinkus Tober‐Lau, et al.
Nature Medicine (2022) Vol. 28, Iss. 3, pp. 477-480
Open Access | Times Cited: 398
Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 392
Antibody-mediated neutralization of SARS-CoV-2
Henning Gruell, Kanika Vanshylla, Timm Weber, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 925-944
Open Access | Times Cited: 117
Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers
Jean‐Louis Bayart, Jonathan Douxfils, Constant Gillot, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1092-1092
Open Access | Times Cited: 113
Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
Bilgin Osmanodja, Simon Ronicke, Klemens Budde, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2565-2565
Open Access | Times Cited: 76
The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2
Jeffrey P. Townsend, Hayley B. Hassler, Pratha Sah, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 31
Open Access | Times Cited: 69
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses
V. Gounant, Valentine Marie Ferré, Ghassen Soussi, et al.
Journal of Thoracic Oncology (2021) Vol. 17, Iss. 2, pp. 239-251
Open Access | Times Cited: 60
Duration of immunity following full vaccination against SARS-CoV-2: a systematic review
Isaac Yeboah Addo, Frederick Dadzie, Sylvester Reuben Okeke, et al.
Archives of Public Health (2022) Vol. 80, Iss. 1
Open Access | Times Cited: 45
Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational study
Linnea Vikström, Peter Fjällström, Yong-Dae Gwon, et al.
The Lancet Regional Health - Europe (2023) Vol. 30, pp. 100646-100646
Open Access | Times Cited: 22
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article
Jérôme Barrière, Michel Carlès, Clarisse Audigier-Valette, et al.
European Journal of Cancer (2021) Vol. 162, pp. 182-193
Open Access | Times Cited: 51
Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, María Ruiz‐Ruigómez, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 12, pp. e1010211-e1010211
Open Access | Times Cited: 50
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
Henning Gruell, Kanika Vanshylla, Pinkus Tober‐Lau, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 45
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
Georg M. N. Behrens, Joana Barros‐Martins, Anne Cossmann, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Persistence of Immune Response in Health Care Workers After Two Doses BNT162b2 in a Longitudinal Observational Study
Jonas Herzberg, Bastian Fischer, Christopher Lindenkamp, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 32
Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults
Kanika Vanshylla, Pinkus Tober‐Lau, Henning Gruell, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 4, pp. 445-446
Open Access | Times Cited: 32
A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: An observational multi-cohort study
Ziyue Wang, Adam Cryar, Oliver Lemke, et al.
EClinicalMedicine (2022) Vol. 49, pp. 101495-101495
Open Access | Times Cited: 28
Frailty impacts immune responses to Moderna COVID-19 mRNA vaccine in older adults
Charles Semelka, Michael DeWitt, Maria Blevins, et al.
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 19
Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination
Vivien Karl, Maike Hofmann, Robert Thimme
Journal of Virology (2025)
Open Access
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study
Timothée Bruel, Laurie Pinaud, Laura Tondeur, et al.
EClinicalMedicine (2022) Vol. 51, pp. 101576-101576
Open Access | Times Cited: 23
Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
Bilgin Osmanodja, Simon Ronicke, Klemens Budde, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 22
Durable immune responses after BNT162b2 vaccination in home-dwelling old adults
Lena Hansen, Karl A. Brokstad, Amit Bansal, et al.
Vaccine X (2023) Vol. 13, pp. 100262-100262
Open Access | Times Cited: 13
The ageing immune system as a potential target of senolytics
Peter Yandi Du, Ankesh Gandhi, Manraj Bawa, et al.
Oxford Open Immunology (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 12
Booster shot of inactivated SARS‐CoV‐2 vaccine induces potent immune responses in people living with HIV
Haoting Zhan, Huixia Gao, Yongmei Liu, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 21
Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine
Estela Giménez, Eliseo Albert, João Zulaica, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e865-e868
Open Access | Times Cited: 19
Sustained but Declining Humoral Immunity Against SARS-CoV-2 at 9 Months Postvaccination With BNT162b2: A Prospective Evaluation in 309 Healthy Individuals
Evangelos Terpos, Vangelis Karalis, Ioannis Ntanasis‐Stathopoulos, et al.
HemaSphere (2021) Vol. 6, Iss. 1, pp. e677-e677
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top